Design and Synthesis of Piperazinylpyridine Derivatives as Novel 5-Ht1a Agonists/5-Ht3 Antagonists for the Treatment of Irritable Bowel Syndrome (IBS)
Chemical and Pharmaceutical Bulletin - Japan
doi 10.1248/cpb.57.34
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2009
Authors
Publisher
Pharmaceutical Society of Japan